HomeICAD • NASDAQ
add
iCAD Inc
Previous close
$1.90
Day range
$1.75 - $1.89
Year range
$1.18 - $2.65
Market cap
49.50M USD
Avg Volume
281.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 4.22M | 3.54% |
Operating expense | 5.76M | 21.00% |
Net income | -1.80M | -31.08% |
Net profit margin | -42.71 | -26.62% |
Earnings per share | -0.07 | -40.00% |
EBITDA | -1.85M | -66.76% |
Effective tax rate | -0.33% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.79M | -1.33% |
Total assets | 37.11M | -19.03% |
Total liabilities | 7.73M | -47.72% |
Total equity | 29.37M | — |
Shares outstanding | 26.35M | — |
Price to book | 1.71 | — |
Return on assets | -13.25% | — |
Return on capital | -16.46% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.80M | -31.08% |
Cash from operations | -1.50M | 4.87% |
Cash from investing | -57.00K | 82.83% |
Cash from financing | — | — |
Net change in cash | -1.56M | -17,433.33% |
Free cash flow | -851.38K | 50.18% |
About
iCAD Inc. is a medical-device manufacturer. Headquartered in Nashua, New Hampshire, iCAD offers computer aided detection to support detection of breast, prostate and colorectal cancers. The iCAD technology platforms also include hardware and software for radiation therapy treatment. Wikipedia
Founded
1984
Headquarters
Website
Employees
68
